Compared to the Control (Tumor) group, the expression of AKT decreased 3.92-fold in the Tumor+50 mg/kg melatonin group, while it decreased 2.18 times in the Tumor+100 mg/kg melatonin group (Figs. 4 and 5). Here, AKT1 is linked to neoplasm.